Brief: Axcella Therapeutics Details Clinical And Operational Milestones For 2022
06/01/2022 14:26
Jan 6 (Reuters) - Axcella Health Inc AXLA.O :
* AXCELLA THERAPEUTICS DETAILS CLINICAL AND OPERATIONAL
MILESTONES
FOR 2022
* AXCELLA HEALTH INC - LONG COVID PHASE 2A TOP-LINE DATA
ANTICIPATED IN MID-2022
* AXCELLA HEALTH INC - EMMPACT℠ PHASE 2B INTERIM DATA IN
NONALCOHOLIC STEATOHEPATITIS (NASH) ANTICIPATED IN MID-2022
Source text for Eikon: ID:nBw66F3Mla
Further company coverage: AXLA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Axcella Health
See all newsAxcella Health Inc expected to post a loss of $1.25 a share - Earnings Preview
Brief: Axcella Health Inc- On Oct 4, Co Received Notice From Nasdaq That Co Had Regained Compliance With Nasdaq
Brief: Axcella Announces Reverse Stock Split Effective September 19, 2023
U.S. STOCKS ON THE MOVE-PDD Holdings, Catalent, Best Buy
Brief: Axcella Granted Patent For Long Covid Fatigue Treatment